251 related articles for article (PubMed ID: 12846775)
1. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A
Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775
[TBL] [Abstract][Full Text] [Related]
2. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
3. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.
Van Tellingen A; Grooteman MP; Bartels PC; Van Limbeek J; Van Guldener C; Wee PM; Nubé MJ
Kidney Int; 2001 Jan; 59(1):342-7. PubMed ID: 11135089
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
[TBL] [Abstract][Full Text] [Related]
5. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
[TBL] [Abstract][Full Text] [Related]
6. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
7. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
8. Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers.
Galli F; Benedetti S; Floridi A; Canestrari F; Piroddi M; Buoncristiani E; Buoncristiani U
Kidney Int; 2005 Feb; 67(2):750-9. PubMed ID: 15673326
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
14. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
15. Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.
De Vriese AS; Langlois M; Bernard D; Geerolf I; Stevens L; Boelaert JR; Schurgers M; Matthys E
Nephrol Dial Transplant; 2003 Dec; 18(12):2596-600. PubMed ID: 14605283
[TBL] [Abstract][Full Text] [Related]
16. A new polymethylmethacrylate membrane for hemodialysis.
Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
[TBL] [Abstract][Full Text] [Related]
17. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?
Ward RA
J Am Soc Nephrol; 2005 Aug; 16(8):2421-30. PubMed ID: 15975998
[TBL] [Abstract][Full Text] [Related]
18. Does hemodiafiltration improve the removal of homocysteine?
Badiou S; Morena M; Bargnoux AS; Jaussent I; Rodriguez A; Leray-Moragues H; Chalabi L; Bosc JY; Canaud B; Cristol JP
Hemodial Int; 2011 Oct; 15(4):515-21. PubMed ID: 22111820
[TBL] [Abstract][Full Text] [Related]
19. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
